This invention discloses a method for efficient soluble expression of
classical swine fever virus (CSFV) E2
protein and a method for preparing highly active
monoclonal antibodies, belonging to the fields of
animal disease detection and bioengineering technology. This invention, through precise optimization of dual sequences,
targeted modification of molecular chaperone vectors, synergistic dual molecular chaperone combinations, temporal induction processes, and a dual screening
system, balances
antigen activity and translation efficiency, improves induction response and expression efficiency, and precisely matches the folding sequence to obtain E2
protein with a soluble content of approximately 86% and a purity ≥95%. The 3B7
monoclonal antibody prepared using this
protein as an
immunogen showed the best performance, with an
ascites titer of 1:96000, and neutralizing titers of 1:5120 and 1:4096 against CSFV Shimen strain and prevalent subtypes, respectively. The
titer decreased by only 4.2% after 3 months of
refrigeration at 4°C, and it specifically recognizes CSFV types 1 and 2 without cross-reactivity with BVDV / BDV. This invention solves the pain points of existing technologies, has low industrialization costs, and provides important
technical support for the precise prevention and control of
classical swine fever.